4-Et-PVP
| 4-Et-PVP | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 5485-65-4 |
| PubChem | 119025 |
| DrugBank | |
| ChemSpider | 106282 |
| KEGG | |
4-Et-PVP (4-Ethyl-α-pyrrolidinopentiophenone) is a synthetic stimulant drug of the cathinone class. It is chemically related to α-PVP and is known for its stimulant effects.
Chemical Properties[edit]
4-Et-PVP is a derivative of pyrrolidinophenone and has the chemical formula C16H23NO. It features a pyrrolidine ring attached to a pentanone chain, with an ethyl group at the para position of the phenyl ring.
Pharmacology[edit]
As a stimulant, 4-Et-PVP acts on the central nervous system (CNS). It is believed to function as a norepinephrine-dopamine reuptake inhibitor (NDRI), similar to other compounds in the cathinone class. This action increases the levels of the neurotransmitters norepinephrine and dopamine in the brain, leading to increased alertness, energy, and euphoria.
Usage and Effects[edit]
4-Et-PVP is typically encountered in the form of a white crystalline powder. It is often used recreationally for its stimulant effects, which can include increased energy, enhanced focus, and euphoria. However, it can also lead to adverse effects such as anxiety, paranoia, and cardiovascular issues.
Legal Status[edit]
The legal status of 4-Et-PVP varies by country. In many places, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use.
Health Risks[edit]
The use of 4-Et-PVP carries significant health risks. Potential adverse effects include tachycardia, hypertension, hyperthermia, and psychosis. Long-term use can lead to addiction and other severe health problems.
See Also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
